Novel in vitro model for high-rate IgA class switching - PubMed (original) (raw)
. 1995 Apr 1;154(7):3156-61.
Affiliations
- PMID: 7897205
Novel in vitro model for high-rate IgA class switching
T M McIntyre et al. J Immunol. 1995.
Abstract
The parameters necessary for induction of high-rate IgA class switching are unknown. Thus, although TGF-beta is switch factor for the IgA class, the percentage of membrane (m)IgA+ cells generated in vitro in response to TGF-beta and various individual modes of B cell activation is limited to 1 to 2% of the total B cell population, a percentage far below that observed within Peyer's patches. In this report we determined a set of parameters that act synergistically to generate up to 15 to 20% mIgA+ cells in vitro. A dual mode of B cell activation is required whereby signaling through CD40 or in response to LPS stimulation must occur in concert with multivalent Ag receptor crosslinking. A complex cytokine requirement is also revealed in that both IL-4 and IL-5 must be present with TGF-beta for high-rate IgA class switching to occur. By contrast, IFN-gamma, a known antagonist of IL-4, strongly suppresses the induction of mIgA+ cells in response to these stimuli. This novel cellular system should serve as a powerful tool for studying the molecular mechanisms that underly the IgA class switch and may provide insight into the physiologic parameters that induce it.
Similar articles
- Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
Snapper CM, Waegell W, Beernink H, Dasch JR. Snapper CM, et al. J Immunol. 1993 Nov 1;151(9):4625-36. J Immunol. 1993. PMID: 8409423 - The roles of IL-4, TGF-beta and LPS in IgA switching.
Kunimoto DY, Ritzel M, Tsang M. Kunimoto DY, et al. Eur Cytokine Netw. 1992 Jul-Aug;3(4):407-15. Eur Cytokine Netw. 1992. PMID: 1421013 - Decision criteria for resolving isotype switching conflicts by B cells.
Deenick EK, Hasbold J, Hodgkin PD. Deenick EK, et al. Eur J Immunol. 2005 Oct;35(10):2949-55. doi: 10.1002/eji.200425719. Eur J Immunol. 2005. PMID: 16180247 - IL-21: a new player in the control of isotype switch in Peyer's patches.
Pistoia V, Cocco C. Pistoia V, et al. J Leukoc Biol. 2009 May;85(5):739-43. doi: 10.1189/jlb.0109045. J Leukoc Biol. 2009. PMID: 19406834 Review. - Cytokine regulation of immunoglobulin isotype switching and expression.
Coffman RL, Savelkoul HF, Lebman DA. Coffman RL, et al. Semin Immunol. 1989 Sep;1(1):55-63. Semin Immunol. 1989. PMID: 15630959 Review.
Cited by
- MZB1 promotes the secretion of J-chain-containing dimeric IgA and is critical for the suppression of gut inflammation.
Xiong E, Li Y, Min Q, Cui C, Liu J, Hong R, Lai N, Wang Y, Sun J, Matsumoto R, Takahashi D, Hase K, Shinkura R, Tsubata T, Wang JY. Xiong E, et al. Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13480-13489. doi: 10.1073/pnas.1904204116. Epub 2019 May 24. Proc Natl Acad Sci U S A. 2019. PMID: 31127044 Free PMC article. - Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta.
Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A. Ostroukhova M, et al. J Clin Invest. 2006 Apr;116(4):996-1004. doi: 10.1172/JCI26490. Epub 2006 Mar 16. J Clin Invest. 2006. PMID: 16543950 Free PMC article. - An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions.
Sangster MY, Riberdy JM, Gonzalez M, Topham DJ, Baumgarth N, Doherty PC. Sangster MY, et al. J Exp Med. 2003 Oct 6;198(7):1011-21. doi: 10.1084/jem.20021745. Epub 2003 Sep 29. J Exp Med. 2003. PMID: 14517272 Free PMC article. - Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases.
Liu JC, Zhang K, Zhang X, Guan F, Zeng H, Kubo M, Lee P, Candotti F, James LK, Camara NOS, Benlagha K, Lei JH, Forsman H, Yang L, Xiao W, Liu Z, Liu CH. Liu JC, et al. MedComm (2020). 2024 Aug 13;5(8):e662. doi: 10.1002/mco2.662. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39144468 Free PMC article. Review. - B-lymphocyte subpopulations in patients with selective IgA deficiency.
Nechvatalova J, Pikulova Z, Stikarovska D, Pesak S, Vlkova M, Litzman J. Nechvatalova J, et al. J Clin Immunol. 2012 Jun;32(3):441-8. doi: 10.1007/s10875-012-9655-6. Epub 2012 Feb 12. J Clin Immunol. 2012. PMID: 22328142
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous